Catalyst Wire Dossier Catalyst Wire Dossier

recombinant coagulation factor IX–albumin fusion protein (rIX-FP)

recombinant coagulation factor IX–albumin fusion protein · CSL Behring
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant coagulation factor IX–albumin fusion protein (rIX-FP), covering 2016-05-09 to 2016-05-09. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Patients With Hemophilia B [Phase 2, Phase 3]

See pricing